Showing results (171-180 of 362) with videos related to
Sort By:
Pageof 37
American Heart Journal|October 23, 2024
Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024Michael Khorsandi, Omar Mhaimeed, Omar Dzaye, et al.JAMA Network Open|June 8, 2019
Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017Jenny S Guadamuz, G Caleb Alexander, Tanya Chaudhri, et al.Journal of General Internal Medicine|July 10, 2004
Barriers to patient-physician communication about out-of-pocket costsG Caleb Alexander, Lawrence P Casalino, Chien-Wen Tseng, et al.Drug and Alcohol Dependence|December 5, 2020
Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016Ju Nyeong Park, Emaan Rashidi, Kathryn Foti, et al.Archives of Internal Medicine|January 13, 2010
Impact of FDA black box advisory on antipsychotic medication useE Ray Dorsey, Atonu Rabbani, Sarah A Gallagher, et al.Journal of Comparative Effectiveness Research|February 22, 2018
Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussionErnest Law, Rachel Harrington, G Caleb Alexander, et al.Plos One|August 17, 2017
The availability of pharmacies in the United States: 2007-2015Dima Mazen Qato, Shannon Zenk, Jocelyn Wilder, et al.BMJ Open|June 11, 2020
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysisHemalkumar B Mehta, Stephan Ehrhardt, Thomas J Moore, et al.O&G Open|September 26, 2025
Induced Abortion and Out-of-State Travel Among Insured Women Before and After the Dobbs v. Jackson Women's Health Organization DecisionIlina C Odouard, Jenny S Guadamuz, Apurba Chakraborty, et al.Pharmacoepidemiology and Drug Safety|September 7, 2018
Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone usersIrene B Murimi, Hsien-Yen Chang, Mark Bicket, et al.Pageof 37